Alembic Pharmaceuticals LimitedNSE: APLLTD

Alembic Pharmaceuticals Limited Press Release Oct 03 2024

· Issued by Alembic Pharmaceuticals Limited via NSE India

Filed with NSE ·

On 6ix: 6ix.com/news/alembic-pharmaceuticals-limited-press-release-oct-03-2024

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 03, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Lamotrigine Extended-Release Tablets USP, 200 mg, 250 mg, and 300 mg.".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases